Sabra Health Care REIT, Inc.
SBRA
$20.31
-$0.01-0.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.49% | -1.03% | -3.28% | -9.73% | 0.73% |
| Total Other Revenue | 51.71% | 46.61% | 37.05% | 26.59% | 16.90% |
| Total Revenue | 25.32% | 21.72% | 15.77% | 7.32% | 7.81% |
| Cost of Revenue | 219.86% | 42.95% | 35.12% | 18.75% | 11.31% |
| Gross Profit | -66.41% | 11.48% | 6.44% | 1.75% | 6.24% |
| SG&A Expenses | 34.40% | 16.77% | 22.07% | 1.26% | -1.78% |
| Depreciation & Amortization | 29.35% | 22.16% | 21.50% | 13.56% | 4.57% |
| Other Operating Expenses | -- | -- | -5,903.23% | -- | -- |
| Total Operating Expenses | 129.04% | 32.28% | 25.43% | 16.09% | 7.20% |
| Operating Income | -140.85% | 3.64% | -0.60% | -8.09% | 8.79% |
| Income Before Tax | -137.21% | 1.53% | -41.29% | -22.25% | 170.52% |
| Income Tax Expenses | 36.42% | 27.36% | 29.21% | 264.53% | 13.73% |
| Earnings from Continuing Operations | -138.52% | 1.26% | -41.86% | -24.41% | 173.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -138.45% | 1.43% | -41.70% | -24.34% | 173.38% |
| EBIT | -140.85% | 3.64% | -0.60% | -8.09% | 8.79% |
| EBITDA | -77.23% | 10.88% | 8.26% | 0.53% | 7.17% |
| EPS Basic | -136.27% | -4.31% | -44.68% | -26.12% | 166.09% |
| Normalized Basic EPS | -233.76% | -2.99% | -17.79% | -15.14% | 7.83% |
| EPS Diluted | -137.04% | -5.55% | -44.68% | -29.19% | 170.00% |
| Normalized Diluted EPS | -235.35% | -3.40% | -17.91% | -15.43% | 7.50% |
| Average Basic Shares Outstanding | 6.01% | 5.99% | 5.40% | 2.39% | 2.74% |
| Average Diluted Shares Outstanding | 4.71% | 6.52% | 5.48% | 2.75% | 3.07% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -3.76% | 0.05% | 0.81% | 0.35% | -0.62% |